|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 114, Issue 4 833-840, Copyright © 1992 by Company of Biologists
JOURNAL ARTICLES |
PJ Miettinen and K Heikinheimo
Department of Pathology, University of Helsinki, Finland.
Transforming growth factor-alpha (TGF-alpha) mRNA is expressed in several pancreatic cancer cell lines, but its expression during normal fetal pancreas development has not been studied. We investigated the expression of TGF-alpha, its receptor (EGF-R) and insulin mRNA and their corresponding peptides in human fetal pancreata (15-20 gestation weeks). Polymerase chain reaction (PCR) and RNAase protection analysis revealed that TGF-alpha and insulin mRNAs were detectable in pancreas during the developmental span studied. In northern blot analysis a single band of 4.8 kilobases (kb) corresponding to the TGF-alpha transcript and a 0.6 kb for the insulin mRNA were detected in the pancreas. Using in situ hybridization, TGF-alpha mRNA expression was seen in a low copy number in both the exo- and endocrine pancreas. By immunohistochemistry TGF-alpha-immunoreactive cells were detected in the ducts, acini and islets showing that the mRNA was translated into protein. By contrast, insulin transcripts were detected in a high copy number, restricted to the islets of Langerhans. However, monoclonal insulin antibody detected less insulin containing cells than could be expected from the mRNA pattern suggesting that fetal beta-cells rapidly secrete insulin instead of storing it in the secretory granules. Alternatively, the translation of insulin mRNA could be inefficient. By double labeling the pancreas sections with polyclonal TGF-alpha antiserum and monoclonal insulin antibody the TGF-alpha- and insulin-like immunoreactivity was localized to beta-cells. Furthermore, mRNA for the TGF-alpha receptor, EGF-R, together with EGF-R-immunoreactive cells were also present in pancreas.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M.-A. Huotari, P. J. Miettinen, J. Palgi, T. Koivisto, J. Ustinov, D. Harari, Y. Yarden, and T. Otonkoski ErbB Signaling Regulates Lineage Determination of Developing Pancreatic Islet Cells in Embryonic Organ Culture Endocrinology, November 1, 2002; 143(11): 4437 - 4446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Heikinheimo, M. A. Laine, O. V-P. Ritvos, R. J. Voutilainen, B. L. M. Hogan, and I. V. Leivo Bone Morphogenetic Protein-6 Is a Marker of Serous Acinar Cell Differentiation in Normal and Neoplastic Human Salivary Gland Cancer Res., November 1, 1999; 59(22): 5815 - 5821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, P. M. Bartold, C. Z. Zhang, R. W. Clarkson, W. G. Young, and M. J. Waters Growth Hormone and Insulin-Like Growth Factor I Induce Bone Morphogenetic Proteins 2 and 4: A Mediator Role in Bone and Tooth Formation? Endocrinology, September 1, 1998; 139(9): 3855 - 3862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-A. Huotari, J. Palgi, and T. Otonkoski Growth Factor-Mediated Proliferation and Differentiation of Insulin-Producing INS-1 and RINm5F Cells: Identification of Betacellulin as a Novel {beta}-Cell Mitogen Endocrinology, April 1, 1998; 139(4): 1494 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kaneto, J.-i. Miyagawa, Y. Kajimoto, K. Yamamoto, H. Watada, Y. Umayahara, T. Hanafusa, Y. Matsuzawa, Y. Yamasaki, S. Higashiyama, et al. Expression of Heparin-binding Epidermal Growth Factor-like Growth Factor during Pancreas Development. A POTENTIAL ROLE OF PDX-1 IN TRANSCRIPTIONAL ACTIVATION J. Biol. Chem., November 14, 1997; 272(46): 29137 - 29143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Sanvito, P. Herrera, J Huarte, A Nichols, R Montesano, L Orci, and J. Vassalli TGF-beta 1 influences the relative development of the exocrine and endocrine pancreas in vitro Development, January 12, 1994; 120(12): 3451 - 3462. [Abstract] [PDF]
|
|
